MedPath

Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer

Phase 2
Terminated
Conditions
Rectal Cancer
Registration Number
NCT00457327
Lead Sponsor
Heidelberg University
Brief Summary

The purpose of this study is to determine whether protective ileostomy is required after low anterior resection due to rectal cancer

Detailed Description

Since introduction of total mesorectal excision prognosis and quality of life of patients with rectal cancer of the middle or lower third of the rectum could be improved significantly. There is no valid data about the need of protective ileostomy in these patients. About 10% of the patients develop insufficiency of the anastomosis and might benefit from ileostomy whereas about 90% would not have required protective ileostomy retrospectively. Aim of the study is to show that protective ileostomy is not required if several criteria are fulfilled and early measures in case of clinical impairment are defined. Therefore eligibility criteria include safely performed stapler anastomosis with complete rings and control of impermeability by air insufflation. In the event of clinical impairment in the postoperative course CT scan with KM filling of the rectum to exclude insufficiency of the anastomosis will be performed. In case of insufficiency protective ileostomy will be created. 40 patients will be included.

Comparison: Patients with resectable rectal cancer of the middle or lower third will be intraoperatively randomized to either protective ileostomy or no ileostomy at all.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • radical resectable rectal cancer
  • low sphincter-preserving resection of carcinomas of the lower and middle third
  • preoperative normal continence
  • preoperative normal sphincter function
  • complete rings after stapler anastomosis
  • impermeability of anastomosis for air
  • written informed consent
Exclusion Criteria
  • reduced cooperation or drug abuse
  • pregnancy
  • psychosis
  • age under 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Morbidity and mortality until day 30 postoperative
Secondary Outcome Measures
NameTimeMethod
Quality of life
Ranking of factors influencing quality of life

Trial Locations

Locations (1)

Clinical Study Center Surgery, Department of Surgery, University of Heidelberg

馃嚛馃嚜

Heidelberg, Germany

漏 Copyright 2025. All Rights Reserved by MedPath